piboserod has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edvardsen, T; Gullestad, L; Kjekshus, JK; Køber, L; Levy, FO; Olsen, IC; Osnes, JB; Qvigstad, E; Sjaastad, I; Skomedal, T; Torp-Pedersen, C | 1 |
| Birkeland, JA; Bjørnerheim, R; Brattelid, T; Krobert, KA; Levy, FO; Moberg, ER; Osnes, JB; Qvigstad, E; Sejersted, OM; Sjaastad, I; Skomedal, T | 1 |
| Birkeland, JA; Enger, U; Levy, FO; Lunde, PK; Qvigstad, E; Sejersted, OM; Sjaastad, I; Swift, F; Tovsrud, N | 1 |
1 trial(s) available for piboserod and Heart Failure
| Article | Year |
|---|---|
Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure.
Topics: Aged; Confidence Intervals; Disease Progression; Double-Blind Method; Exercise Test; Female; Health Status Indicators; Heart Failure; Heart Ventricles; Humans; Indoles; Male; Natriuretic Peptide, Brain; Oxazines; Peptide Fragments; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Stroke Volume; Surveys and Questionnaires; Treatment Outcome; Ventricular Function, Left; Walking | 2009 |
2 other study(ies) available for piboserod and Heart Failure
| Article | Year |
|---|---|
Effects of treatment with a 5-HT4 receptor antagonist in heart failure.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Heart Failure; Indoles; Isoproterenol; Lung; Male; Myocardial Contraction; Myocardium; Organ Size; Piperidines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin, 5-HT4; RNA, Messenger; Serotonin 5-HT4 Receptor Antagonists; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Calcium Signaling; Calcium-Binding Proteins; Cardiac Myosins; Cardiotonic Agents; Coronary Vessels; Disease Models, Animal; Heart Failure; Indoles; Isoproterenol; Ketanserin; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Myosin Light Chains; Phosphorylation; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT4; Sarcoplasmic Reticulum; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Time Factors; Troponin I; Ventricular Function | 2007 |